Endra Life Sciences Inc (NDRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NDRA | TMO | ISRG | EW | DXCM |
| Company | Endra Life Sciences Inc | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Edwards Lifesciences Corp | Dexcom Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 0.3440 | 579.84 | 380.00 | 85.85 | 127.22 |
| High | 0.3440 | 579.84 | 384.47 | 86.95 | 129.22 |
| Low | 0.3020 | 571.63 | 378.87 | 85.20 | 126.91 |
| Last | 0.3267 | 572.38 | 381.36 | 85.25 | 128.37 |
| Change | -0.0053 | +1.13 | +3.71 | +0.19 | +1.72 |
| % Change | -1.60% | +0.20% | +0.98% | +0.22% | +1.36% |
| Volume | 61,000 | 1,749,600 | 1,028,800 | 2,327,100 | 1,778,900 |
| 20-Day Average Volume | 121,695 | 1,437,555 | 1,473,430 | 2,989,750 | 2,961,450 |
| Previous Close | 0.3320 | 571.25 | 377.65 | 85.06 | 126.65 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2907 | 566.87 | 377.87 | 88.02 | 133.31 |
| 20-Day Raw Stochastic | 60.40% | 70.89% | 60.04% | 18.21% | 27.99% |
| 20-Day Relative Strength | 34.38% | 51.63% | 51.12% | 41.97% | 46.40% |
| Weighted Alpha | -79.98 | +8.72 | +27.65 | +1.47 | +11.77 |
| Today's Opinion | 88% Sell | 56% Buy | 56% Buy | 40% Buy | 56% Buy |
| Previous Opinion | 88% Sell | 56% Buy | 40% Buy | 40% Buy | 40% Buy |
| Last Month's Opinion | 100% Sell | 80% Buy | 64% Buy | 80% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +29.39% since 04/26/24 | -0.21% since 04/26/24 | +1.61% since 04/26/24 | -1.37% since 04/26/24 | +3.24% since 04/26/24 |
| Low | 0.2500 on 04/29/24 | 565.49 on 05/02/24 | 367.39 on 05/02/24 | 83.50 on 05/01/24 | 123.07 on 04/29/24 |
| High | 0.3799 on 05/02/24 | 581.90 on 05/01/24 | 384.47 on 05/03/24 | 87.21 on 04/29/24 | 129.22 on 05/03/24 |
| 1-Month | |||||
| %Chg | -6.34% since 04/03/24 | -0.63% since 04/03/24 | -0.54% since 04/03/24 | -8.35% since 04/03/24 | -7.32% since 04/03/24 |
| Low | 0.2210 on 04/17/24 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 83.50 on 05/01/24 | 123.07 on 04/29/24 |
| High | 0.4000 on 04/04/24 | 589.93 on 04/09/24 | 393.66 on 04/05/24 | 94.37 on 04/04/24 | 141.99 on 04/09/24 |
| 3-Month | |||||
| %Chg | -67.97% since 02/02/24 | +3.73% since 02/02/24 | -0.63% since 02/02/24 | -0.98% since 02/02/24 | +6.13% since 02/02/24 |
| Low | 0.2210 on 04/17/24 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 82.53 on 02/07/24 | 113.05 on 02/28/24 |
| High | 1.2800 on 02/15/24 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 142.00 on 03/26/24 |
| 6-Month | |||||
| %Chg | -65.97% since 11/03/23 | +25.87% since 11/03/23 | +36.92% since 11/03/23 | +27.11% since 11/03/23 | +31.72% since 11/03/23 |
| Low | 0.2210 on 04/17/24 | 437.26 on 11/10/23 | 269.49 on 11/10/23 | 63.88 on 11/10/23 | 91.49 on 11/08/23 |
| High | 2.7900 on 12/21/23 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 142.00 on 03/26/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,664 | 218,054,112 | 133,954,720 | 51,257,152 | 50,366,680 |
| Shares Outstanding, K | 11,036 | 381,714 | 354,706 | 602,600 | 397,684 |
| Annual Sales | 0 | 42,857,000,000 | 7,124,100,000 | 6,004,800,000 | 3,622,300,000 |
| Annual Net Income | -10,060,000 | 5,995,000,000 | 1,798,000,000 | 1,402,400,000 | 541,500,000 |
| Last Quarter Sales | 0 | 10,345,000,000 | 1,890,600,000 | 1,598,200,000 | 921,000,000 |
| Last Quarter Net Income | -1,460,000 | 1,327,000,000 | 544,900,000 | 351,900,000 | 146,400,000 |
| 60-Month Beta | 1.13 | 0.80 | 1.39 | 1.10 | 1.23 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.17 on 03/28/24 | 5.11 on 04/24/24 | 1.50 on 04/18/24 | 0.66 on 04/25/24 | 0.32 on 04/25/24 |
| Latest Earnings Date | 05/20/24 | 04/24/24 | 04/18/24 | 04/25/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.390 on 03/14/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | 03/14/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 26.60 | 79.42 | 33.06 | 75.83 |